跳至主要内容
临床试验/IRCT20211004052674N1
IRCT20211004052674N1招募中未知

Comparison of serum profile of inflammatory cytokines in high or unfavorable intermediate-risk localized prostate cancer patients treated with definitive whole pelvis radiation therapy plus external beam boost versus high dose rate brachytherapy boost.

Ahvaz University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Male

入选标准

  • Age =18 year
  • Eastern Cooperative Oncology Group (ECOG) performance zero or one
  • Localized prostate adenocarcinoma confirmed by pathology with moderate (Unfavorable) and high risk according to National Comprehensive Cancer Network criteria(NCCN) (first edition 2021)

排除标准

  • Severe physical illness or mental disorder that, according to the researcher, prevents treatment according to the protocol
  • Patients who cannot be followed up regularly
  • Contraindications for external radiotherapy or brachytherapy
  • Previous history of external radiotherapy or prostate brachytherapy
  • History of any prostate surgery
  • Any history of malignancy (except for non-melanoma skin cancers)
  • History of Chemotherapy, Targeted Therapy and the use of immunosuppressive drugs
  • History of chronic infectious diseases (HIV, viral hepatitis, etc.)

研究者

相似试验

Comparison of serum profile of inflammatory... | 临床试验